enGene Therapeutics Inc. Common Stock (ENGN)
enGene Therapeutics Inc. Common Stock (ENGN) has reported earnings 9 times since Mar 11, 2024. The stock moves an average of ±5.31% the day after reporting, closing higher 44.4% of the time. Its largest post-earnings gain was +4.05% (Dec 22, 2025) and its largest decline was -18.97% (Mar 09, 2026). The next earnings report is predicted for 2026-09-10 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±5.31%
Positive %
44.4%
Negative %
55.6%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 09, 2026 | ☀ PRE | $8.22 | $8.39 | $7.05 | 60,974 | -18.97% | open_in_new |
| Dec 22, 2025 | ☽ POST | $8.90 | $8.91 | $8.89 | 2,364 | +4.05% | open_in_new |
| Sep 11, 2025 | ☽ POST | $5.91 | $6.09 | $6.09 | 603 | -6.9% | open_in_new |
| Jun 12, 2025 | ☀ PRE | $3.22 | $3.22 | $3.13 | 4,942 | -2.8% | open_in_new |
| Mar 10, 2025 | ☽ POST | $5.01 | $5.01 | $5.01 | 164 | +0% | open_in_new |
| Dec 19, 2024 | ☽ POST | $5.90 | $5.90 | $5.82 | 1,339 | -1.37% | open_in_new |
| Sep 10, 2024 | ☽ POST | $6.50 | $6.50 | $6.50 | 182 | +3.62% | open_in_new |
| Jun 14, 2024 | ☀ PRE | $9.45 | $10.00 | $9.00 | 12,753 | -10.04% | open_in_new |
| Mar 11, 2024 | ☽ POST | $16.00 | $16.23 | $16.21 | 552 | +0% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±5.31%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
4 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260610 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260514 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260513 | open_in_new SEC.gov |
Frequently asked about ENGN earnings
When does enGene Therapeutics Inc. Common Stock report earnings next? expand_more
enGene Therapeutics Inc. Common Stock (ENGN)'s next earnings date is estimated for 2026-09-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ENGN stock move after earnings? expand_more
Over 9 reports, ENGN has moved an average of ±5.31% the session after earnings, closing higher 44.4% of the time.
What was ENGN's biggest post-earnings move? expand_more
ENGN's largest post-earnings gain on record was +4.05% on Dec 22, 2025, and its largest decline was -18.97% on Mar 09, 2026.
Where can I find enGene Therapeutics Inc. Common Stock's SEC filings? expand_more
All of enGene Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right